Prognostic factor of the two-year mortality after revascularization in patients with critical limb ischemia

Vascular. 2017 Apr;25(2):123-129. doi: 10.1177/1708538116651216. Epub 2016 Jul 9.

Abstract

Purposes The aim of this study was to evaluate the risk factors for the two-year survival after revascularization of critical limb ischemia. Methods Between 2008 and 2012, 142 patients underwent revascularization. A retrospective analysis was performed to measure the risk factor. Results A total 85 patients underwent surgical revascularization, 31 patients underwent endovascular therapy while 26 patients underwent hybrid therapy. By multivariate analysis, the following variables were considered to be risk factors: ejection fraction <50 % (HR, 3.14; 95% CI, 1.22-7.95; P = 0.02), serum albumin level <2.5 g/dL (HR, 3.45; 95% CI, 1.01-11.7; P = 0.04) and nonambulatory status (HR, 4.11; 95% CI, 1.79-9.70; P < 0.01). The two-year survival rate of the patients with no risk factors was 85.5%, while the patients with at least one risk factor had an unfavorable prognosis (one; 56.7%, two; 45.4%). Conclusions The nonambulatory status, serum albumin level <2.5 g/dL and ejection fraction <50% were the risk factors for the two-year mortality after revascularization in critical limb ischemia patients. These risk factors may be useful for the treatment strategy of critical limb ischemia patients.

Keywords: Critical limb ischemia; bypass; endovascular therapy; prognostic factor.

MeSH terms

  • Aged
  • Biomarkers / blood
  • Critical Illness
  • Endovascular Procedures / adverse effects
  • Endovascular Procedures / mortality*
  • Female
  • Health Status
  • Humans
  • Hypoalbuminemia / blood
  • Hypoalbuminemia / mortality
  • Ischemia / diagnostic imaging
  • Ischemia / mortality
  • Ischemia / therapy*
  • Kaplan-Meier Estimate
  • Lower Extremity / blood supply*
  • Male
  • Mobility Limitation
  • Peripheral Arterial Disease / diagnostic imaging
  • Peripheral Arterial Disease / mortality
  • Peripheral Arterial Disease / therapy*
  • Proportional Hazards Models
  • Retrospective Studies
  • Risk Factors
  • Serum Albumin / analysis
  • Serum Albumin, Human
  • Stroke Volume
  • Time Factors
  • Treatment Outcome
  • Vascular Surgical Procedures / adverse effects
  • Vascular Surgical Procedures / mortality*

Substances

  • ALB protein, human
  • Biomarkers
  • Serum Albumin
  • Serum Albumin, Human